Therapeutics
Reference:
Potter, Barry, 2005. Therapeutics. A61K31/4425-WO2005054198 (A2), 16 June 2005.
Related documents:
This repository does not currently have the full-text of this item.You may be able to access a copy if URLs are provided below.
Abstract
The present invention relates to the use of a compound of formula (I); wherein: R1 comprises a carbonyl group and R2 is a hydrocarbyl group; optionally wherein said ring is further substituted; or a pharmaceutically acceptable salt thereof; in the manufacture of a medicament for use in one or more of: modulating the release of intracellular calcium from a store controlled by nicotinic acid adenine dinucleotide phosphate; modulating calcium spikes in mammalian cells; treating diseases in one or more of brain, heart, pancreatic cells (e.g. pancreatic acinar and pancreatic beta cells), immune cells, T-cells, haemopoietic cells including phagocytes; treating diseases in one or more of brain, heart, pancreatic cells (e.g. pancreatic acinar and pancreatic beta cells), immune cells, T-cells, haemopoietic cells including phagocytes by modulating the release of intracellular calcium from a store controlled by nicotinic acid adenine dinucleotide phosphate; treating diseases in one or more of brain, heart, and T-cells by modulating calcium spikes in mammalian cells.
Details
| Item Type | Patent |
| Creators | Potter, B., Dowden, J. and Galione, A. |
| Uncontrolled Keywords | 4425 |
| Departments | Faculty of Science > Pharmacy & Pharmacology |
| Status | Published |
| ID Code | 30763 |
Export
Actions (login required)
| View Item |
